Cardiothoracic Surgery

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary artery bypass surgery
  • Valve repair/replacement
  • Surgery for adult congenital heart disease
  • Minimally Invasive Heart Surgery
  • Ventricular Assist Devices (VADs)
Learn More
Cardiac Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung and esophageal cancers
  • Emphysema
  • Hyperhidrosis
  • Hiatal hernia
  • Pericardial & Pleural Effusions
  • Thoracentesis
Learn More
Thoracic Surgery team

Why Choose Weill Cornell?

New Advances

Leading by Example

Cardiothoracicc surgeon Erin Mills Iannacone, MD, aims not only to bring more women to her field, but to broaden NYP/Weill Cornell's surgical offerings

Click here to learn more about the article

Symposium: Advances in Thoracic Oncology

The course is a one day, in depth meeting focused on updating healthcare providers on advances in thoracic oncology. Participants will be able to identify the advances in the management of patients with lung cancer.

Marfan: 2018 The Walk for Victory

Weill Cornell Medicine/NewYork-Presbyterian invite you to join us on Sunday, June 10, 2018 at Hudson River Park at 57th Street here in New York City, to raise awareness and funds for the 5th Annual NYC Walk for Victory benefitting The Marfan Foundation.

Weill Cornell Medicine/NewYork-Presbyterian will be your team!! Led by Walk for Victory chair Dr. Leonard N. Girardi, funds raised through this event provide support and education, as well as the research support necessary to make sure people with Marfan syndrome and related disorders can live longer and fuller lives. This serious connective tissue disease affects most systems of the human body – eyes, bones and spine, heart and blood vessels. There are many ways to cope with Marfan syndrome but gone undiagnosed, it can be fatal.

For more details: 2018 The Walk for Victory

Study Looks at the “Harms” of Lung Cancer Screening

By Brendon M. Stiles, MD

May 7, 2018

It was a privilege to present our clinical research, “Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?” at the 98th American Association of Thoracic Surgery (AATS) Annual Meeting last week in San Diego. I was pleased that the AATS recognized the importance of our message by placing the presentation in one of the featured plenary sessions.

Here is a link to the article: "Study Looks at the "Harms" of Ling Cancer Screening"

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.

Current Clinical Trials

 

US News National 2017-18

The Weill Cornell Medicine's Department of Cardiothoracic Surgery is proud to partner with NewYork-Presbyterian, ranked #3 in Adult Cardiology & Heart Surgery Hospital in the nation and #1 in NYC by U.S. News and World Report.